Additionally, the toxicity of DUX4 makes modeling FSHD even more challenging, both in vitro and in vivo, as its expression is quickly followed by cell death, meaning that models are difficult to propagate and offer only a small window to study DUX4 activity. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.